Thoratec Corporation Device Just Missed Goal; FDA Panel to Review Device
WASHINGTON - A Thoratec Corp study of an experimental implanted heart pump showed it narrowly missed a preset goal to gauge effectiveness, U.S. medical device reviewers said in documents released on Wednesday. Government health advisers will consider Friday whether a mechanical heart pump from Thoratec Corp. should be approved, despite missing a key effectiveness goal in a company study. Read article below.